Target intelligence / Profile preview

Ribosomal protein L30 pseudogene 6 (RPL30P6)

Target: RPL30P6
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L30 pseudogene 6 (RPL30P6) is a processed pseudogene of the RPL30 gene, which encodes a component of the 60S large ribosomal subunit. Processed pseudogenes, such as RPL30P6, arise through the reverse transcription and insertion of mRNA from functional genes into the genome, but they generally lack regulatory elements and are non-functional. RPL30P6 does not produce a functional protein and is not currently known to have a role in disease or as a drug target. It serves primarily as a genomic marker of past retrotransposition events, characteristic of many ribosomal protein gene families[5][6].

Other names: RPL30_4_501RPL30P6

Beyond the preview

Go deeper on Ribosomal protein L30 pseudogene 6 (RPL30P6).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L30 pseudogene 6 (RPL30P6).

Explore the full profile